| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
| 05/29/2001 | CA2218031C Plant cell growth factor |
| 05/29/2001 | CA2171638C The semaphorin gene family |
| 05/29/2001 | CA2043762C Lipopeptide deacylase |
| 05/29/2001 | CA2031803C Improvements in or relating to glycopeptide deriveratives |
| 05/25/2001 | WO2001036979A2 Placental human neurokinin b precursor |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036454A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 05/25/2001 | WO2001036453A2 Ny-eso-1 nanopeptide derivatives, and uses thereof |
| 05/25/2001 | WO2001036452A2 Heteroclitic analogs of class i epitodes |
| 05/25/2001 | WO2000078956A8 Novel pyrrhocoricin-derived peptides, and methods of use thereof |
| 05/25/2001 | WO2000078801A3 Insulin-like growth factor agonist molecules |
| 05/25/2001 | WO2000073326A3 Redox-stable, non-phosphorylated cyclic peptide inhibitors of sh2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2391531A1 Placental human neurokinin b precursor |
| 05/25/2001 | CA2386341A1 Heteroclitic analogs and related methods |
| 05/23/2001 | EP1101499A2 Diagnostic agents for pancreatic exocrine function |
| 05/23/2001 | EP1101113A1 Cell-signaling assays |
| 05/23/2001 | EP1100969A1 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 05/23/2001 | EP1100947A1 Method for the production of an antibiotic agent |
| 05/23/2001 | EP1100912A1 Method for screening of modulators of calcineurin activity |
| 05/23/2001 | EP1100829A2 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases |
| 05/23/2001 | EP1100823A2 Novel peptides for use in immunotherapy of autoimmune diseases |
| 05/23/2001 | EP1100818A1 Inhibitors of hiv membrane fusion |
| 05/23/2001 | EP1100816A1 Aerothricin analogs, their preparation and use |
| 05/23/2001 | EP1100815A1 Protease susceptibility ii |
| 05/23/2001 | EP1100535A1 Targeting pharmaceutical agents to injured tissues |
| 05/23/2001 | EP1100520A1 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP0815259B1 Modulation of the binding properties of nucleic acid binding partners |
| 05/23/2001 | EP0789709B1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 05/23/2001 | CN1296494A New compound |
| 05/22/2001 | US6235877 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 05/22/2001 | US6235876 Liquid phase process for the preparation of GNRH peptides |
| 05/22/2001 | US6235872 Genetic engineering |
| 05/22/2001 | US6235717 Pharmaceutical compounds |
| 05/22/2001 | US6235714 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 05/22/2001 | US6235712 Non-aqueous polar aprotic peptide formulations |
| 05/22/2001 | US6235525 Nucleotide sequence; diagnosis; vaccines; transfected cell line |
| 05/17/2001 | WO2001034640A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 05/17/2001 | WO2001034637A1 Novel physiologically active peptides and process for producing the same |
| 05/17/2001 | WO2001034635A2 Methods and compositions for peptide synthesis |
| 05/17/2001 | WO2001034631A2 PEPTIDE ANALOGS AND MIMETICS SUITABLE FOR IN VIVO USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ABNORMAL PROTEIN FOLDING INTO AMYLOID, AMYLOID-LIKE DEPOSITS OR β-SHEET RICH PATHOLOGICAL PRECURSOR THEREOF |
| 05/17/2001 | WO2001034171A2 Peptides for treatment of erectile dysfunction |
| 05/17/2001 | WO2001034095A2 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
| 05/17/2001 | WO2001005810A3 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN αVβ¿6? |
| 05/17/2001 | WO2000078796A3 Labeled neurotensin derivatives with improved resistance to enzymatic degradation |
| 05/17/2001 | US20010001309 For treating pathologies related to altered alpha v beta 3 integrin-mediated cell attachment, in particular wherein inhibition of angiogenesis is desired, for example in tumors, also associated with metastasis |
| 05/17/2001 | DE19953732A1 New human virus-inhibiting peptide, useful e.g. for treating viral or other infections or cancer, comprises fragment of alpha1-antitrypsin |
| 05/17/2001 | CA2390854A1 Peptides for treatment of erectile dysfunction |
| 05/17/2001 | CA2389392A1 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
| 05/17/2001 | CA2389041A1 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or .beta.-sheet rich pathological precursor thereof |
| 05/17/2001 | CA2378086A1 Methods and compositions for peptide synthesis |
| 05/16/2001 | EP1099693A1 Radiolabelled peptide compounds |
| 05/16/2001 | EP1098903A1 Novel method for preparing cyclosporin derivatives |
| 05/16/2001 | EP1098902A1 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 05/16/2001 | EP0810870B1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/16/2001 | CN1295578A Pharmaceuticals for imaging of angiogenic disorders |
| 05/16/2001 | CN1295577A Method for searching physiologically active substances, process for producing these substances and drugs found by searching method |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1295079A Liquid phase synthesis process of peptide chain containing glutamine and asparamide and its intermediate |
| 05/16/2001 | CN1065874C Novel peptides, preparation and use thereof |
| 05/15/2001 | US6232290 Cyclic hexapeptides with antimicrobial activity |
| 05/15/2001 | US6232287 Peptide targets prostate gland; diagnosis; drug delivery; biochemical conjugation |
| 05/15/2001 | US6231864 Strategically modified hepatitis B core proteins and their derivatives |
| 05/15/2001 | CA2291456A1 Diagnostic agents for pancreatic exocrine function |
| 05/15/2001 | CA2195975C An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides |
| 05/15/2001 | CA2183268C Bispecific molecules having clinical utilities |
| 05/15/2001 | CA2041638C Recombinant polynucleotide constructs suitable for providing secretion of pai-2 |
| 05/15/2001 | CA1341231C Primary biliary cirrhosis autoantigen |
| 05/10/2001 | WO2001032906A2 Oligomers and oligomeric segments of alpha-hydroxy carboxylic acids and alpha-amino acids |
| 05/10/2001 | WO2001032848A1 Mimic cellulose binding domain |
| 05/10/2001 | WO2001032692A2 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them |
| 05/10/2001 | WO2000033888A9 Prodrug compounds and process for preparation thereof |
| 05/10/2001 | CA2389233A1 Oligomers and oligomeric segments of alpha-hydroxy carboxylic acids and alpha-amino acids |
| 05/10/2001 | CA2386440A1 Mimic cellulose binding domain |
| 05/09/2001 | EP1097945A2 Monoclonal and chimeric antibody specific for human tumor necrosis factor |
| 05/09/2001 | EP1097168A2 Compounds and methods for modulating cadherin-mediated functions |
| 05/09/2001 | EP1097164A1 Processes for coupling amino acids using bis-(trichloromethyl) carbonate |
| 05/09/2001 | CN1294517A Immunoglobulin molecules having synthetic variable region and modified specificity |
| 05/09/2001 | CN1065438C Cyclic adhesion inhibitors |
| 05/08/2001 | US6228989 Peptide substrates phosphorylated by P21-activated protein kinase |
| 05/08/2001 | US6228987 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 05/08/2001 | US6228983 Peptides from transmembrane protein, gp41, from human immunodeficiency virus; viricides; drug screening; intracellular modulators of coiled-coil peptide structures |
| 05/08/2001 | US6228982 Stable compounds that form double-stranded, helical structures mimicking double-stranded dna; diagnosis; prophylaxis; therapy; antisense agents |
| 05/08/2001 | US6228841 Peptide derivatives |
| 05/08/2001 | US6228840 Administering n-anisoylated heptapeptide to inhibit melanocyte stimulating hormone; treating melanomas |
| 05/08/2001 | US6228834 Treating gramnegative bacterial infections; neutralizing lipopolysaccharides |
| 05/08/2001 | US6228374 Polypeptides and immunology |
| 05/08/2001 | US6228373 Peptide dimer, glycine, cystine or prolne amino acid for immunology |
| 05/08/2001 | CA2096010C Recombinant feline coronavirus s proteins |
| 05/08/2001 | CA2087003C Hrsv vaccine |
| 05/03/2001 | WO2001031036A2 Modified viral surface proteins which bind to cells of tumor vasculature |
| 05/03/2001 | WO2001031020A1 Disulfide conjugated cell toxins and methods of making and using them |
| 05/03/2001 | WO2001030809A1 Cyclic peptides and aids vaccines |
| 05/03/2001 | WO2001030371A2 Novel chimeric analgesic peptides |
| 05/03/2001 | WO2000068263A3 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 05/03/2001 | CA2390084A1 Novel chimeric analgesic peptides |
| 05/03/2001 | CA2389196A1 Cyclic peptides and aids vaccines |
| 05/03/2001 | CA2388165A1 Disulfide conjugated cell toxins and methods of making and using them |